Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02703090 · ClinicalTrials.gov registry record · NA
Near Infrared Spectroscopy Cortical Response to Noxious and Auditory Stimuli in Subjects Under General Anesthesia
A NA study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT02703090 is a NA study that has completed, run by Boston Children's Hospital. The registered enrollment target is 44 participants.
The verdict
NCT02703090, a NA study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The primary aim is to utilize near-infrared spectroscopy (NIRS) in patients under general anesthesia to measure changes in brain blood flow in the bilateral somatosensory cortices and the prefrontal cortices in response to noxious stimulation.
Interventions
- DRUG Normal saline
- DRUG Remifentanil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2016-10 |
| Est. Completion | 2020-03-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02703090
The ClinicalTrials.gov registry entry for NCT02703090 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal saline is the first listed.
NCT02703090 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02703090 about?
NCT02703090 is a clinical study titled "Near Infrared Spectroscopy Cortical Response to Noxious and Auditory Stimuli in Subjects Under General Anesthesia". The primary aim is to utilize near-infrared spectroscopy (NIRS) in patients under general anesthesia to measure changes in brain blood flow in the bilateral somatosensory cortices and the prefrontal cortices in response to noxious stimulation.
What is the current status of trial NCT02703090?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2016-10. Estimated completion is 2020-03-10.
What interventions are being tested in trial NCT02703090?
The interventions under investigation include: Normal saline (DRUG), Remifentanil (DRUG).
Who is sponsoring clinical trial NCT02703090?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.